Publications

5891 Results

PROSPECT-LUNG: A National Clinical Trials Network Trial Advancing Pragmatic Innovation in Cancer Clinical Trials

Authors
Booth A
Journal / Conference
Journal of Thoracic Oncology. 2026 Feb 24; 103650. DOI: 10.1016/j.jtho.2026.103650.
Year
2026
Research Committee(s)
Lung
PMID
PMID41747891

Composition of Health Care Contact Days and Mortality Prediction Among Older Adult Clinical Trial Participants

Authors
Gupta A;Till C;LeBlanc ML;Hershman DL;Unger JM
Journal / Conference
JCO Oncology Practice. 2026 Apr 1; OP-25-01182. DOI: 10.1200/OP-25-01182.
Year
2026
Research Committee(s)
Cancer Care Delivery

Reassessing Treatment Outcomes Following Immune-Related Adverse Events-Reply

Authors
Unger JM
Journal / Conference
JAMA Oncology. 2026 Apr 23; . DOI: 10.1001/jamaoncol.2026.0785. Letter (reply RE 10.1001/jamaoncol.2025.5549 [PubID 6714])
Year
2026

Incorporating Intensity Modulated Total Body Irradiation (IMRT-TBI) Into Future Cooperative Group Clinical Trials: An NRG Hematologic Malignancies Working Group-Led Report From the National Clinical Trials Network

Authors
Kovalchuk N
Journal / Conference
International Journal of Radiation Oncology, Biology, Physics. 2026 Feb 17; S0360-3016(26)00388-3. DOI: 10.1016/j.ijrobp.2026.02.201. Online ahead of print
Year
2026
PMID
PMID41713515

Integrating Oncology APPs and Clinical Pharmacists into Clinical Cancer Research

Authors
Braun-Inglis C
Journal / Conference
Journal of the National Cancer Institute. 2026 Apr 21; djag125. DOI: 10.1093/jnci/djag125.
Year
2026

Cancer statistics, 2026: Charting a course for a national cancer research agenda

Authors
Lara PN;Hershman DL
Journal / Conference
CA: A Cancer Journal for Clinicians. 2026 Jan 13; 76: e70061. DOI: 10.3322/caac.70061. editorial
Year
2026
Research Committee(s)
Multiple sites

Consensus radiation therapy organ at risk constraints for NCTN trials in hematologic malignancies

Authors
Sim AJ
Journal / Conference
Journal of the National Cancer Institute. 2026 Apr 7; djag112. DOI: 10.1093/jnci/djag112.
Year
2026

Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial

Authors
Shadman M
Journal / Conference
JAMA Oncology. 2026 Feb 26; e260042. DOI: 10.1001/jamaoncol.2026.0042. Online ahead of print
Year
2026
Research Committee(s)
Lymphoma
PMID
PMID41746629
Study Number(s)
S0016

Long-term follow-up of S0221, comparing alternative dose schedules of anthracycline/taxane therapy in early breast cancer

Authors
Ali A
Journal / Conference
JNCI Cancer Spectrum. 2026 Mar 14; pkag024. DOI: 10.1093/jncics/pkag024. Online ahead of print
Year
2026
Research Committee(s)
Breast
PMID
PMID41832961
Study Number(s)
S0221

DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix

Authors
Chae YK
Journal / Conference
Journal for ImmunoTherapy of Cancer. 2026 Feb 11; 14: e012805. DOI: 10.1136/jitc-2025-012805.
Year
2026
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID41672597
Study Number(s)
S1609